Insulin recombinant human PCE and 2 more items
State & local contract award Virginia Awarded
- Contract number
- A247_PC_TXN00615470
- Awardee
- Life Technologies Corporation
- Contracting organization
- George Mason University
- Cumulative value
- $149.23
About this award
George Mason University awarded a contract to Life Technologies Corporation on July 21, 2026, for the procurement of laboratory reagents and associated handling services. The contract, identified as A247_PC_TXN00615470, is valued at $149.00 and represents a single transaction for delivery to GMU Purchasing in Virginia. The primary deliverable consists of recombinant human insulin, a critical biological reagent used in research and development applications.
The contract line items include recombinant human insulin priced at $74.73, a minimum handling charge of $47.00 to cover processing and logistics, and a dry ice charge of $27.50 to ensure proper temperature-controlled transportation and preservation of the biological material. These supplementary charges reflect the specialized handling requirements necessary for maintaining the integrity of temperature-sensitive biological products during delivery and storage at the George Mason University facility.
Line items
| Item | Total |
|---|---|
| Insulin recombinant human PCE | $74.73 |
| Min handling charge FR CAT PCE | $47.00 |
| Dry ICE charge PCE | $27.50 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A247_PC_TXN00615470?
Contract A247_PC_TXN00615470 was awarded to Life Technologies Corporation by George Mason University in Virginia on July 21, 2026.
How much is contract A247_PC_TXN00615470 worth?
Its cumulative value is $149.23.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award